Symbols / EQ Stock $2.08 +1.96% Equillium, Inc.

Healthcare • Biotechnology • United States • NCM
EQ (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NCM · United States
Market Cap 131.51M
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $2.04
Price $2.08
Change 1.96%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest EQ news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
-100.00%
41.09
+13.89%
36.08
+128.97%
15.76
Operating Revenue
0.00
-100.00%
41.09
+13.89%
36.08
+128.97%
15.76
Operating Expense
23.63
-52.12%
49.36
-2.45%
50.61
-7.63%
54.79
Research And Development
12.84
-65.69%
37.43
+1.05%
37.04
-1.35%
37.55
Selling General And Administration
10.79
-9.59%
11.94
-12.02%
13.57
-21.30%
17.24
General And Administrative Expense
10.79
-9.59%
11.94
-12.02%
13.57
-21.30%
17.24
Other Gand A
10.79
-9.59%
11.94
-12.02%
13.57
-21.30%
17.24
Total Expenses
23.63
-52.12%
49.36
-2.45%
50.61
-7.63%
54.79
Operating Income
-23.63
-185.81%
-8.27
+43.06%
-14.52
+62.79%
-39.03
Total Operating Income As Reported
-23.63
-185.81%
-8.27
+43.06%
-14.52
+76.61%
-62.08
EBITDA
-23.52
-189.20%
-8.13
+33.00%
-12.14
+80.19%
-61.26
Normalized EBITDA
-23.52
-189.20%
-8.13
+33.00%
-12.14
+68.23%
-38.21
Reconciled Depreciation
0.12
-15.33%
0.14
+8.73%
0.13
+6.78%
0.12
EBIT
-23.63
-185.81%
-8.27
+32.58%
-12.26
+80.02%
-61.38
Total Unusual Items
—
—
0.00
+100.00%
-23.05
Total Unusual Items Excluding Goodwill
—
—
0.00
+100.00%
-23.05
Special Income Charges
—
—
0.00
+100.00%
-23.05
Other Special Charges
—
—
—
23.05
Net Income
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Pretax Income
-22.40
-190.66%
-7.71
+39.58%
-12.76
+79.57%
-62.43
Net Non Operating Interest Income Expense
0.83
-39.68%
1.38
-25.07%
1.84
+391.15%
-0.63
Interest Expense Non Operating
—
0.00
-100.00%
0.49
-53.37%
1.05
Net Interest Income
0.83
-39.68%
1.38
-25.07%
1.84
+391.15%
-0.63
Interest Expense
—
0.00
-100.00%
0.49
-53.37%
1.05
Interest Income Non Operating
0.83
-39.68%
1.38
-40.83%
2.33
+455.71%
0.42
Interest Income
0.83
-39.68%
1.38
-40.83%
2.33
+455.71%
0.42
Other Income Expense
0.40
+149.27%
-0.82
-976.32%
-0.08
+99.67%
-22.77
Other Non Operating Income Expenses
0.40
+149.27%
-0.82
-976.32%
-0.08
-127.05%
0.28
Tax Provision
0.00
-100.00%
0.36
-37.76%
0.58
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Net Income From Continuing Operation Net Minority Interest
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Net Income From Continuing And Discontinued Operation
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Net Income Continuous Operations
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Normalized Income
-22.40
-177.65%
-8.07
+39.51%
-13.34
+66.14%
-39.38
Net Income Common Stockholders
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Diluted EPS
-0.39
-69.57%
-0.23
+39.47%
-0.38
+79.46%
-1.85
Basic EPS
-0.39
-69.57%
-0.23
+39.47%
-0.38
+79.46%
-1.85
Basic Average Shares
57.30
+62.07%
35.36
+1.82%
34.73
+2.96%
33.73
Diluted Average Shares
57.30
+62.07%
35.36
+1.82%
34.73
+2.96%
33.73
Diluted NI Availto Com Stockholders
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Line Item Trend 2023-12-31
Total Assets
50.53
Current Assets
49.35
Cash Cash Equivalents And Short Term Investments
40.87
Cash And Cash Equivalents
23.22
Other Short Term Investments
17.65
Receivables
6.29
Accounts Receivable
3.73
Other Receivables
0.50
Taxes Receivable
2.05
Prepaid Assets
1.96
Other Current Assets
0.23
Total Non Current Assets
1.18
Net PPE
1.11
Gross PPE
1.48
Accumulated Depreciation
-0.36
Properties
0.00
Machinery Furniture Equipment
0.66
Other Properties
0.80
Leases
0.02
Other Non Current Assets
0.07
Total Liabilities Net Minority Interest
27.96
Current Liabilities
27.57
Payables And Accrued Expenses
11.40
Payables
4.71
Accounts Payable
4.71
Current Accrued Expenses
6.70
Total Tax Payable
0.00
Income Tax Payable
0.00
Current Debt And Capital Lease Obligation
0.44
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
0.44
Current Deferred Liabilities
15.73
Current Deferred Revenue
15.73
Total Non Current Liabilities Net Minority Interest
0.38
Long Term Debt And Capital Lease Obligation
0.38
Long Term Debt
—
Long Term Capital Lease Obligation
0.38
Non Current Deferred Liabilities
0.00
Non Current Deferred Revenue
0.00
Stockholders Equity
22.57
Common Stock Equity
22.57
Capital Stock
0.00
Common Stock
0.00
Share Issued
35.25
Ordinary Shares Number
35.25
Treasury Shares Number
0.00
Additional Paid In Capital
208.17
Retained Earnings
-185.74
Gains Losses Not Affecting Retained Earnings
0.14
Other Equity Adjustments
0.14
Total Equity Gross Minority Interest
22.57
Total Capitalization
22.57
Working Capital
21.78
Invested Capital
22.57
Total Debt
0.82
Capital Lease Obligations
0.82
Net Tangible Assets
22.57
Tangible Book Value
22.57
Interest Payable
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-22.75
-19.55%
-19.03
+12.66%
-21.78
-149.43%
-8.73
Cash Flow From Continuing Operating Activities
-22.75
-19.55%
-19.03
+12.66%
-21.78
-149.43%
-8.73
Net Income From Continuing Operations
-22.40
-177.65%
-8.07
+39.51%
-13.34
+78.64%
-62.43
Depreciation Amortization Depletion
0.12
-15.33%
0.14
+8.73%
0.13
+6.78%
0.12
Depreciation
0.12
-15.33%
0.14
+8.73%
0.13
+6.78%
0.12
Depreciation And Amortization
0.12
-15.33%
0.14
+8.73%
0.13
+6.78%
0.12
Other Non Cash Items
—
-15.73
-71.53%
-9.17
-118.97%
48.33
Stock Based Compensation
2.32
-38.08%
3.75
-6.18%
4.00
-17.43%
4.84
Operating Gains Losses
-0.46
-157.30%
0.79
+1268.97%
0.06
-77.69%
0.26
Net Foreign Currency Exchange Gain Loss
-0.47
-159.70%
0.79
+1268.97%
0.06
-77.69%
0.26
Gain Loss On Sale Of PPE
0.02
0.00
—
—
Change In Working Capital
-2.32
-375.18%
0.84
+133.07%
-2.55
-13500.00%
0.02
Change In Receivables
0.00
-100.00%
3.73
+516.39%
-0.90
+68.39%
-2.84
Changes In Account Receivables
0.00
-100.00%
3.73
+516.39%
-0.90
+68.39%
-2.84
Change In Prepaid Assets
1.26
-44.48%
2.27
+226.04%
-1.80
-1042.41%
-0.16
Change In Payables And Accrued Expense
-3.62
+29.79%
-5.16
-3152.66%
0.17
-94.25%
2.94
Change In Accrued Expense
-1.69
+46.74%
-3.16
-471.12%
-0.55
-228.24%
0.43
Change In Payable
-1.94
+2.91%
-2.00
-375.93%
0.72
-71.17%
2.51
Change In Account Payable
-1.94
+2.91%
-2.00
-375.93%
0.72
-71.17%
2.51
Change In Other Working Capital
0.04
+566.67%
-0.01
+30.77%
-0.01
-117.33%
0.07
Change In Other Current Assets
—
—
—
—
Change In Other Current Liabilities
—
—
—
—
Investing Cash Flow
4.46
-67.68%
13.81
+390.09%
-4.76
-125.49%
18.68
Cash Flow From Continuing Investing Activities
4.46
-67.68%
13.81
+390.09%
-4.76
-125.49%
18.68
Net PPE Purchase And Sale
-0.04
+57.65%
-0.09
-70.00%
-0.05
+82.08%
-0.28
Purchase Of PPE
-0.05
+43.53%
-0.09
-70.00%
-0.05
+82.08%
-0.28
Sale Of PPE
0.01
0.00
—
—
Capital Expenditure
-0.05
+43.53%
-0.09
-70.00%
-0.05
+82.08%
-0.28
Net Investment Purchase And Sale
4.50
-67.62%
13.90
+394.97%
-4.71
-125.80%
18.26
Purchase Of Investment
0.00
+100.00%
-17.60
+67.83%
-54.71
-265.67%
-14.96
Sale Of Investment
4.50
-85.71%
31.50
-37.00%
50.00
+50.49%
33.23
Net Business Purchase And Sale
—
—
0.00
-100.00%
0.70
Financing Cash Flow
30.43
+18453.05%
0.16
+101.78%
-9.23
-659.51%
-1.22
Cash Flow From Continuing Financing Activities
30.43
+18453.05%
0.16
+101.78%
-9.23
-659.51%
-1.22
Net Issuance Payments Of Debt
—
0.00
+100.00%
-9.13
-539.12%
-1.43
Repayment Of Debt
—
0.00
+100.00%
-9.13
-539.12%
-1.43
Long Term Debt Payments
—
0.00
+100.00%
-9.13
-539.12%
-1.43
Net Long Term Debt Issuance
—
0.00
+100.00%
-9.13
-539.12%
-1.43
Net Common Stock Issuance
0.68
0.00
+100.00%
-0.26
0.00
Common Stock Payments
—
0.00
+100.00%
-0.26
0.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.26
0.00
Proceeds From Stock Option Exercised
29.75
+18037.20%
0.16
-0.61%
0.17
-22.90%
0.21
Changes In Cash
12.14
+340.59%
-5.05
+85.89%
-35.77
-509.49%
8.74
Effect Of Exchange Rate Changes
0.05
+156.63%
-0.08
+29.66%
-0.12
-2460.00%
0.01
Beginning Cash Position
18.09
-22.10%
23.22
-60.72%
59.11
+17.35%
50.37
End Cash Position
30.28
+67.41%
18.09
-22.10%
23.22
-60.72%
59.11
Free Cash Flow
-22.79
-19.27%
-19.11
+12.47%
-21.83
-142.27%
-9.01
Interest Paid Supplemental Data
—
0.00
-100.00%
0.95
+11.69%
0.85
Income Tax Paid Supplemental Data
—
0.00
-100.00%
0.58
0.00
Amortization Of Securities
-0.01
+98.14%
-0.75
+17.51%
-0.91
-819.69%
0.13
Common Stock Issuance
0.68
0.00
—
0.00
Issuance Of Capital Stock
0.68
0.00
—
0.00
Sale Of Business
—
—
0.00
-100.00%
0.70
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category